Harmon Cyrus 4
4 · Olema Pharmaceuticals, Inc. · Filed Jul 27, 2026
Research Summary
AI-generated summary of this filing
Olema Pharmaceuticals (OLMA) Director Harmon Cyrus Sells 25,000 Shares
What Happened
Harmon Cyrus, a director of Olema Pharmaceuticals, sold a total of 25,000 shares in two open-market transactions: 12,500 shares on July 23, 2026 at about $11.58 per share (≈ $144,738) and 12,500 shares on July 24, 2026 at about $11.71 per share (≈ $146,425), for combined proceeds of roughly $291,163. These were sales (not purchases or option exercises).
Key Details
- Transaction dates and prices:
- 2026-07-23: 12,500 shares sold; reported price shown as $11.58; filing footnote reports weighted average $11.579 and price range $11.52–$11.675 (F1).
- 2026-07-24: 12,500 shares sold; reported price shown as $11.71; filing footnote reports weighted average $11.714 and price range $11.70–$11.775 (F2).
- Total proceeds: approximately $291,163.
- Shares held/ownership: shares were held by Harmon Family Investors LLC, of which the reporting person is the manager (F3). The filing excerpt provided does not state the number of shares owned after these transactions.
- Filing timeliness: Report filed 2026-07-27; this is within the Form 4 two-business-day filing window for the reported trades.
- Additional note: Footnotes state a per-price breakdown is available to the SEC, issuer, or security holders on request.
Context
These transactions were open-market sales from a family-held LLC (not gifts or option exercises). Sales are often routine and do not by themselves indicate the director’s view of the company’s prospects; purchases typically carry more weight for signaling. The filing discloses weighted average price ranges and the manager relationship to the holding entity for transparency.
Insider Transaction Report
- Sale
Common Stock
[F1]2026-07-23$11.58/sh−12,500$144,738→ 715,270 total - Sale
Common Stock
[F2]2026-07-24$11.71/sh−12,500$146,425→ 702,770 total
- 117,028(indirect: See Footnote)
Common Stock
[F3]
Footnotes (3)
- [F1]The weighted average sale price for the transaction reported was $11.579, and the range of prices were between $11.52 and $11.675. Upon request from the SEC staff, the issuer, or any security holder of the issuer, full information regarding the number of shares sold at each separate price will be provided.
- [F2]The weighted average sale price for the transaction reported was $11.714, and the range of prices were between $11.70 and $11.775. Upon request from the SEC staff, the issuer, or any security holder of the issuer, full information regarding the number of shares sold at each separate price will be provided.
- [F3]The shares are held by the Harmon Family Investors LLC, of which the Reporting Person is the manager.